Holen Sie sich die Stockscreener-App
5.41
0.18%
-0.010
Schlusskurs vom Vortag:
$5.42
Offen:
$5.43
24-Stunden-Volumen:
203.40K
Relative Volume:
0.77
Marktkapitalisierung:
$244.14M
Einnahmen:
-
Nettoeinkommen (Verlust:
$-32.74M
KGV:
-6.5976
EPS:
-0.82
Netto-Cashflow:
$-24.89M
1W Leistung:
-0.73%
1M Leistung:
-0.18%
6M Leistung:
-0.18%
1J Leistung:
-56.93%
1-Tages-Spanne:
$5.40
$5.445
1-Wochen-Bereich:
$5.40
$5.465
52-Wochen-Spanne:
$3.18
$16.02
Third Harmonic Bio Inc Stock (THRD) Company Profile
Firmenname
Third Harmonic Bio Inc
Sektor
Branche
Telefon
(209) 727-2457
Adresse
1700 MONTGOMERY STREET, SAN FRANCISCO
Vergleichen Sie THRD mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
THRD
Third Harmonic Bio Inc
|
5.41 | 244.59M | 0 | -32.74M | -24.89M | -0.82 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.65 | 121.28B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.10 | 60.96B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
328.81 | 42.77B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
591.99 | 36.21B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
291.47 | 32.08B | 3.81B | -644.79M | -669.77M | -6.24 |
Third Harmonic Bio Inc Stock (THRD) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-03-28 | Herabstufung | Stifel | Buy → Hold |
| 2025-02-12 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2025-02-11 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2024-08-09 | Hochstufung | Morgan Stanley | Equal-Weight → Overweight |
| 2024-06-18 | Eingeleitet | Stifel | Buy |
| 2024-06-07 | Eingeleitet | Raymond James | Outperform |
| 2022-12-16 | Herabstufung | Jefferies | Buy → Hold |
| 2022-12-15 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
| 2022-10-10 | Eingeleitet | Cowen | Outperform |
| 2022-10-10 | Eingeleitet | Jefferies | Buy |
| 2022-10-10 | Eingeleitet | Morgan Stanley | Overweight |
Alle ansehen
Third Harmonic Bio Inc Aktie (THRD) Neueste Nachrichten
Third Harmonic Bio Inc. Company Revenue and Profit Trends: A Deep DiveFree Predictions - Newser
What is the risk reward ratio of investing in Third Harmonic Bio Inc. stockCapitalize on emerging market sectors - jammulinksnews.com
When is Third Harmonic Bio Inc. stock expected to show significant growthAchieve superior capital gains with smart trades - jammulinksnews.com
What institutions are buying Third Harmonic Bio Inc. stock nowFree Risk Assessment Services - Newser
What analysts say about Third Harmonic Bio Inc. stockTremendous financial leverage - PrintWeekIndia
Will Third Harmonic Bio Inc. stock split in the near futureHigh-yield growth strategies - jammulinksnews.com
Layoff Tracker: Flagship Unicorns Tessera, Generate:Biomedicines Downsize - BioSpace
What drives Third Harmonic Bio Inc. stock priceFree Stock Movement Tracking - jammulinksnews.com
Third Harmonic Bio Inc. Stock Analysis and ForecastGame-changing capital returns - jammulinksnews.com
Is Third Harmonic Bio Inc. a good long term investmentDouble or triple returns - jammulinksnews.com
Third Harmonic Bio to delist from Nasdaq and announces liquidation distribution - Investing.com India
Third Harmonic Bio Plans Nasdaq Delisting by July 31 - TipRanks
Is CARV a good long term investmentGame-changing capital returns - Autocar Professional
Services Limited (505502) Stock RalliesFree Wealth Planning Blueprint - jammulinksnews.com
Best IPO Stocks in India Stock Market Opportunity FinderFree Consultation - jammulinksnews.com
Why BCE Inc. stock is on top investor watchlistsWatchlist Winner Update - Newser
How high can AISPW stock price go in 2025Quick Profit Idea Stream - Newser
Fierce Biotech Layoff Tracker 2025: Sarepta lays off 500 staffers; GSK trims R&D team - Fierce Biotech
What makes Third Harmonic Bio Inc. stock price move sharplyPro Trader Stock Focus - Newser
Why Third Harmonic Bio Inc. stock attracts strong analyst attentionFree Low-Risk Investment Plans - beatles.ru
Why LODE stock attracts strong analyst attentionHigh Reward Risk Balanced Trading - Newser
Why PCO(pecunio) Will ExplodeMomentum Swing Watchlist - Newser
How MGNX stock performs during market volatilityFree Investment Portfolio Suggestions - Newser
What makes RBB Bancorp stock price move sharplyFree Step-by-Step Investment Guide - Newser
Finanzdaten der Third Harmonic Bio Inc-Aktie (THRD)
Umsatz
Nettogewinn
Free Cashflow
ENV
Third Harmonic Bio Inc-Aktie (THRD) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Conner Edward R. | Chief Medical Officer |
Nov 08 '24 |
Sale |
15.00 |
2,117 |
31,755 |
0 |
| BVF PARTNERS L P/IL | See Explanation of Responses |
Oct 29 '24 |
Sale |
14.30 |
1,000,000 |
14,300,000 |
176,692 |
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Option Exercise |
4.20 |
2,673 |
11,227 |
2,673 |
| Conner Edward R. | Chief Medical Officer |
Oct 28 '24 |
Sale |
15.00 |
2,673 |
40,095 |
0 |
0.97%
0.22%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):